Humans repeatedly exposed to a cold environment during Antarctic residence. Am. J. Physiol. 254 (Endocrinol. develop characteristic physiological changes, which some Metab. 17): E733-E739, 1988. --Very little is known regarding authors have called adaptive (21). However, earlier studhormonal adaptation in human subjects who are exposed to the extremes of temperature and light that are found in polar ies have not established consistent serum hormonal latitudes. We have previously reported a 50% elevation in the changes that correlate with these known physiological serum thyrotropin (TSH) response to thyrotropin-releasing differences. One possible explanation for these conflicthormone (TRH), a fall in serum total triiodothyronine (T) and ing results to date has been the application of widely free T, (fT:,), and no change in serum total thyroxine (T,) or disparate stimuli. Ambient temperature, altitude, durafree T 4 (fT 4 ) after 42 wk of Antarctic cold exposure. To differ-tion, and interval between cold exposures, age, nutrientiate between central and peripheral mechanisms that may tional state, clothing, and physical activity all differ in lead to these changes, we report the effect of sequentially these various reports. increasing oral doses of T:1 (Cytomel) on serum T, and fMI
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THYROID FUNCTION IN ANTARCTICA tion of T 3 , or an altered sensitivity of the hypothalamic 2S pituitary axis to endogenous T,. We thus prospectively 22 ,-studied the responses to increasing doses of orally ad-W ministered triiodothyronine (Cytomel, Smith Kline & U French, Philadelphia, PA) of both serum T 3 and fr 3 , and the suppression of the TSH response to TRH before, Z V during, and at the completion of 42 wk of continuous ,-* Antarctic residence. The basal diet consisted of 2,000-2,500 kcalories (kcal), with -40% as carbohydrate, 35% as protein, and 12.5, 12.5, 12.5, and 12.5 ug. Doses were administered at 25% as fat. During the Antarctic residence, the calories 1000, 1400, 1800, 2200, and 0200 during the 3-day period. consumed per subject increased to 3,000-3,500 kcal/day, Pill boxes were collected and pills were counted to assure but the relative contributions from carbohydrate, pro-compliance with the protocol. This dosing interval was tein, and fat remained the same.
used to optimize the balance between near steady-state Basal and dynamic thyroid function testing were per-T 3 serum levels, a minimum of sleep deprivation (26), formed in September, 1982, during mission training in and maximal TSH suppression (41) as well as to allow Port Hueneme, CA (i.e., at sea level and with average comparison with similar dosing intervals previously pubtemperature of 20 ± 5°C). The subjects were then trans-lished by our laboratory (4). Basally, before Cytomel, ported to McMurdo Sound, Antarctica, for duty. Thyroid serum was collected for T 3 , and a TSH stimulation test testing was repeated at the completion of the austral was carried out. At each dose level (25, 50, and 75 Mg/ summer (March of 1983), after 20 wk of exposure, and day), serum was collected at 0800 for T 3 , fr 3 , and TSH, again at the end of the austral winter (August of 1983), and a TRH stimulation test was performed. The TSH after a total of 42 continuous wk of exposure.
response to TRH was carried out in nonfasted subjects Each subject wore standard military polar clothing at 0800 on each of the 3 days by measuring the initial during outdoor activity; however, the face and hands serum TSH value and the value at 15, 30, 45, and 60 min were often exposed with this uniform. The subjects were after the bolus intravenous administration of 250 Ag of similar with regard to the amount of out-of-door expo-TRH (17, 31, 12). The integrated TSH response to TRH sure each experienced throughout the study (2.8 ± 0.7 h/ was expressed using Simpson's approximation for disday). Because of the physical nature of the base, each crete intervals. All similar hormone samples were coassubject was exposed not <0.25 h/day on two separate sayed. occasions during each of 294 days of the study, thus Serum T 4 (normal 5.3-10.5 gg/dl) and T 3 (normal 80-serving as a model of multiple repeated environmental 204 ng/dl) were measured commercially by radioexposures. Ambient temperature was recorded during immunoassay (RIA) performed by Nichols Institute (Los each evaluation period (Fig. 1) . Each subject's cold ex-Angeles, CA). Serum fT 4 (normal 1.3-3.8 ng/dl) and fr, posure time per 24 h was also recorded and correlated to (normal 260-480 pg/dl) levels, measured by dialysis techthe observed hormonal changes. Indoor fluorescent light-nique, were also determined by Nichols Institute. Serum ing was used during the austral winter months, and all TSH was measured by RIA (normal 1.5-6 MIU/ml); eight subjects maintained routine 8-h sleep/wake pat-Kallsted Laboratories, Austin, TX). The lower limit of terns, with an indoor temperature of 15.5-20.0°C.
the TSH assay was 1.5 IU/ml. The T., resin uptake was At each study period (warm control, 20 and 42 wk), measured by solid-phase 25I radioassay (Diagnostic subjects underwent basal measurements of serum T 4 , Products, Los Angeles, CA). The "normalized" free T 4 fT 4 , T 3 , T., resin uptake (T 3 RU), TSH, and TSH response index was calculated as the T3 resin uptake value divided to TRH. At each study period, after obtaining basal by a normal pool T 3 resin uptake (0.35) and then multisamples, the subjects were administered sequentially in-plied by the total T 4 . creasing doses of T 3 at levels of 25, 50, and 75 ug/day Statistical analysis was performed by using analysis of respectively, on 3 successive days. The 25-g/day dose of variance with repeated measures and Duncan's multipleTq was divided into five doses of 5 Mg; the 50-g/day dose range test for differences between means (Statpak verwas divided into five doses of 12.5, 12.5, 10, 10, and 5 ug; sion 4.1, Northwest Analytical, Portland, OR). Generaand the 75-Mug/day dose was divided into five doses of 25, tion of three single variable regression curves (one con-
trol, one at 20 wk, and one at 42 wk) of the serum Tj, analysis of variance with two repeated measures (Presponse to incremental doses of T 3 produced the family 0.009). of T 3 dose-response curves shown in Fig. 3 . Comparisons between the curves were done by two-way analysis of T, 3 The mean ± SE T 4 value of 6.0 ± 0.4 g/dl obtained after 20 wk of exposure and the T 4 value of 6.3 ± 0.3 "g/ TSH Response to TRH (Fig. 5 ) dl after 42 wk of exposure were not different than the Basal: without oral T 3 administration. Static TSH control T 4 of 6.4 ± 0.4 ug/dl measured in a warm climate, serum levels, after 20 and 42 wk of cold exposure, were The fT 4 remained unchanged after 20 and 42 wk of 2.9 ± 0.4 and 2.2 ± 0.3 gIU/ml, respectively, and these exposure (1.7 ± 0.1 and 1.9 ± 0.1 ng/dl, respectively), values were not statistically different than the warm when these were compared with a control value of 2.0 ± control basal value of 2.1 ± 0.3 tIU/ml. However, the 0.1 ng/dl.
integrated TSH response to TRH markedly increased from a control value of 502 ± 77 to 699 ± 70 IU . min'. T3 RU and fT 4 Index ( Table 1) m1-1 after 20 wk, and this value remained elevated with The T 3 RU increased slightly throughout the observa-a value of 688 ± 67 jiIU.min-'.ml' after 42 wk of tion period, from a control value of 31.2 ± 1.0% to a Antarctic residence (P < 0.01). The mean (±SE) paired value of 33.9 ± 0.8% after 42 wk of cold exposure (P < increases of the TSH response over control non-T 3 -0.05). There were no differences between the values treated values were 54 ± 14 and 52 ± 14% after 20 and obtained after 20 and 42 wk of polar living. The free T 4 42 wk, respectively. index (fT41) remained unchanged through the study After oral T 3 administration (Fig. 5) . The TSH reperiod, sponse was equally attenuated by oral T 3 both before and after cold exposure. The absolute integrated TSH response values during suppression with 25, 50, and 75 Mg! Serum T, ( Table 2, Figs. 2 and 3) day ofT 3 remained higher when measured after 20 wk of The serum T 3 values, measured basally and after each exposure (386 ± 33, 183 + 15, 121 ± 10 IU.min' .ml-') incremental dose of oral T 3 , were lower after 20 (P = compared with warm climate control values of 134 ± 24, 0.01) and 42 (P = 0.05) wk compared with control values 140 ± 14, 96 ± 4 glU. min'. ml -' (Fig. 5) . The absolute by two-way analysis of variance with two repeated meas-TSH response values after 42 wk (373 ± 50, 191 ± 20, ures (P = 0.03), when all doses and dates are combined. 117 ± 8 UIU . min' . ml-', respectively) remained elevated above warm climate controls (P < 0.05) but were not Serum fT3 (Table Z, Fig. 4 ) different than corresponding values obtained after 20 wk of exposure. However, the mean percentage suppression The serum fT 3 after T 3 administration tended to de-of the TSH response in our subjects at each dose level of cline after 20 wk; however, this change was not statisti-T3 was not different either before or after cold exposure. cally significant. The fT 3 declining trend, which contin-Before deployment, the TSH response was suppressed ued during the measurements at 42 wk, was significantly by 48 ± 6, 68 + 4, and 77 ± 4% after respective doses of different with respect to date when analyzed by two-way 25, 50, and 75 jg/day. These decrements did not change 4 ds T4, total thyroxine; fT,, free thyroxine; T1, total triiodothyronine; TRU, T, resin uptake; fTl, normalized free T4 index; T/T., total T,-tototal T. ratio; IS, insufficient sample. * P < 0.05 compared with control. controls.
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The serum total and free T 3 values (after T3 administration) in the present study were lower when measured after 42 wk of cold exposure compared with basal warm winter. Our subjects varied from this group in that they were well clothed and exposed intermittently to a cold with the same dose of T, after 20 and 42 wk. The values environment for 11 continuous months. were 44 ± 2, 73 ± 2, and 82 ± 2%, respectively after 20
The augmented TSH response to TRH observed in wk, and 47 + 3, 72 ± 1, and 82 ± 2%, respectively after the present study confirms our earlier observations (27). 42 wk of Antarctic residence. The calculated dose needed This test of TSH reserve is reliably reproducible (6-12% to suppress the TSH response by 50% is 29 ± 4 ug/day cv) in the same subjects (17, 31). An elevated nonstimand this dose was not different before or after 42 wk of ulated serum TSH in Antarctic residents and in the cold exposure.
residents of northern Finland has been observed (9, 39). However, the insensitivity of our TSH assay in the low Exposure and Diet ranges may have precluded us from detecting basal nonEven though the amount of consumed calories in-stimulated differences. Others have not been able to creased, there was no significant increase in body weight detect a change in the seasonal TSH response to TRH throughout the observation period. Occupationally re-in normal subjects residing in midlatitude temperate lated activities were similar in both the control and cold climates (17, 31). The differences between these studies environment. All members of the party were similarly and our own are most likely a result of the severity of exposed to the cold environment (2.8 ± 0.7 h/day). There cold environment in the polar latitudes compared with was no correlation between an individual's mean expo-midlatitude temperate climates. sure time per day and any hormonal changes noted
The possible mechanisms to account for decreased throughout the 42 wk of polar living, serum T, and fT levels include decreased production of T 3 (4, 40), increased metabolic clearance of T:j (2, 5, 33), DISCUSSION and decreased absorption of oral T, after chronic cold exposure and/or circadian variation (24) . Any postulated The population residing in the polar latitudes has mechanism must take into account a balanced T 4 econincreased recently since the discovery of fossil fuel de-omy, because T, was unchanged. Integrated thyrotropin (TSH) response to thyrotropin-recontrol by using 2-way analysis of variance with respect to date as a leasing hormone (mean ± SE) measured in 9 subjects before and after treatment.
25, 50, and 75 pLg/day of T,. This response was measured in a warm control climate (0) and after 20 (w) and 42 wk (UJ) cold exposure. There
We feel that decreased production of T., as found in was no difference between results obtained after 20 and 42 wk cold *the sick euthyroid syndrome or during hypocaloric feed-exposure. MOG, microgram. * P < 0.05 compared with warm control ing cannot account for our findings because serum T 3 in climate values. our subjects was not "normalized" after oral T, admin-described. istration (4, 16, 40) . Additionally, if decreased peripheral Increased degradation of T3 and T 4 has been described production of T:) was a significant contributing factor in in rodent models chronically exposed to cold (2, 33). this setting, one should observe a lowering of the T 3 /T 4 ldtyoiedsoa a eicesdb ubro ratio and an increase in reverse T,,, neither of which has mechanisms including nonspecific hepatic induction as been noticed in the previous group observed in this occurs with phenytoin (Dilantin) (36) or catecholamines setting (27). Also, the increased caloric consumption seen (22) or via increased enterohepatic circulation (5). It is in our subjects should lead to increased serum T:1 levels interesting to note that elevated plasma catecholamine as demonstrated by Danforth et al. (6). However, the levels do occur during acute cold exposure (25). If inpresent study documented lower serum T,-levels, leading creased disposal of T3 plays a significant role in our us to implicate other factors to explain the changes observations, we would expect to find lowered serum T,
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THYROID FUNCTION IN ANTARCTICA after administered oral T 3 , a finding we describe herein. T 3 and fT 3 levels before and after oral T 3 administration Ingbar et al. (15) suggest such a mechanism during severe implies an increased metabolic clearance of T 3 and a and prolonged human cold exposure by using iodine decreased negative feedback on TSH secretion by circuclearance studies, when they described increased thy-lating T 3 . The specific metabolic implications of these roidal iodide turnover in cold-exposed human subjects. findings and how they may relate to human environmenAlso, in support of a proposed clearance mechanism, tal adaptation require further study. Konno Although we cannot exclude decreased absorption of REFERENCES orally administered T 3 as a possible mechanism, this explanation is unlikely in that T 3 is consistently well observed, and iodine intake did not change to our knowl- 
